Table 2 Assessment of breast changes (skin erythema) during the treatment course and clinical follow-up at 3 months
From: Three-dimensional surface imaging in breast cancer: a new tool for clinical studies?
Timepoint | baseline | week 1 | week 2 | week 3 | week 4 | week 5 | week 6 | week 7 | follow-up |
|---|---|---|---|---|---|---|---|---|---|
Overall | 0.0 | 2.9 | 14.7 | 36.8 | 77.3 | 100.0 | 100.0 | 66.7 | 3.7 |
CF-RT | 0.0 | 0.0 | 7.7 | 46.7 | 92.9 | 100.0 | 100.0 | 66.7 | 0.0 |
HF-RT | 0.0 | 4.8 | 19.0 | 30.4 | 50.0 | NA | NA | NA | 5.6 |